{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation

May 14, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its featured placement in a BioMedWire editorial focused on emerging CNS drug delivery technologies addressing challenges in Alzheimer’s disease and biodefense research. The editorial highlights the company’s proprietary intranasal nose-to-brain delivery platform, designed to bypass the blood-brain barrier and enable direct therapeutic delivery to the central nervous system, reflecting growing interest in advanced drug delivery approaches for neurological treatment.


Hormuz Closure Puts EV Manufacturing at Risk

May 14, 2026The continued disruption in the Strait of Hormuz is becoming a growing threat to the global electric vehicle industry. Although the crisis is widely linked to rising oil prices, its impact now stretches much further.


China to Regulate EV Battery Recycling

May 14, 2026Chinese authorities are implementing regulations to formalize electric vehicle battery recycling markets as informal operations have captured roughly 70% of retired battery volumes, creating safety and environmental concerns. New EV battery recycling rules would require end-of-life batteries to remain with vehicles through authorized recycling channels, rather than entering unregulated networks where small operators disassemble and resell components.


Alphabet to Offer Yen-Denominated Bonds to Fund AI Ambitions

May 14, 2026As major technology companies pour billions into AI, two of the sector’s biggest names are increasingly turning to overseas debt markets to support rising costs tied to the fast-moving AI race. As AI systems become more advanced, companies like Datavault AI Inc.


Study Suggests Testosterone Slows Glioblastoma Progression in Men

May 14, 2026New research funded by the NIH has uncovered a link between androgens in men and brain tumors. The preclinical study found that men with low levels of testosterone tended to have shorter survival times when diagnosed with glioblastoma when compared to those that had higher levels of this male sex hormone.


BioMedNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Receives 2026 Healthcare Innovation Award for Drug Resistance Research

May 14, 2026Kairos Pharma (NYSE American: KAPA) announced it has been named a winner in the 2026 GHP Magazine Healthcare & Pharmaceutical Awards, receiving recognition as the USA leader in drug resistance development. The award highlights the company’s work in advancing cancer therapeutics designed to address treatment resistance, underscoring Kairos’ focus on extending the effectiveness of existing cancer therapies through innovative drug resistance-targeting approaches.